BR112018011965A2 - método de terapia fotodinâmica (pdt) para câncer de bexiga - Google Patents

método de terapia fotodinâmica (pdt) para câncer de bexiga

Info

Publication number
BR112018011965A2
BR112018011965A2 BR112018011965A BR112018011965A BR112018011965A2 BR 112018011965 A2 BR112018011965 A2 BR 112018011965A2 BR 112018011965 A BR112018011965 A BR 112018011965A BR 112018011965 A BR112018011965 A BR 112018011965A BR 112018011965 A2 BR112018011965 A2 BR 112018011965A2
Authority
BR
Brazil
Prior art keywords
bladder cancer
photodynamic therapy
pdt
bladder
treatment
Prior art date
Application number
BR112018011965A
Other languages
English (en)
Portuguese (pt)
Inventor
Godal Aslak
Hestdal Kjetil
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of BR112018011965A2 publication Critical patent/BR112018011965A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/307—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the urinary organs, e.g. urethroscopes, cystoscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A61N2005/061—Bladder and/or urethra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR112018011965A 2015-12-17 2016-12-19 método de terapia fotodinâmica (pdt) para câncer de bexiga BR112018011965A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15200938 2015-12-17
PCT/EP2016/081809 WO2017103285A1 (en) 2015-12-17 2016-12-19 Method of photodynamic therapy (pdt) for bladder cancer

Publications (1)

Publication Number Publication Date
BR112018011965A2 true BR112018011965A2 (pt) 2018-12-04

Family

ID=55066354

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018011965A BR112018011965A2 (pt) 2015-12-17 2016-12-19 método de terapia fotodinâmica (pdt) para câncer de bexiga

Country Status (18)

Country Link
US (2) US11235168B2 (https=)
EP (1) EP3389716B1 (https=)
JP (1) JP6995755B2 (https=)
KR (1) KR102787192B1 (https=)
CN (2) CN119345612A (https=)
AU (1) AU2016372575B2 (https=)
BR (1) BR112018011965A2 (https=)
CA (1) CA3008552C (https=)
CL (1) CL2018001612A1 (https=)
DK (1) DK3389716T3 (https=)
ES (1) ES2910034T3 (https=)
IL (1) IL259925B (https=)
MX (1) MX385912B (https=)
PL (1) PL3389716T3 (https=)
RU (1) RU2745194C2 (https=)
SG (1) SG11201805000RA (https=)
WO (1) WO2017103285A1 (https=)
ZA (1) ZA201804530B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018011965A2 (pt) * 2015-12-17 2018-12-04 Photocure Asa método de terapia fotodinâmica (pdt) para câncer de bexiga
CN110420326A (zh) * 2019-09-17 2019-11-08 上海复旦张江生物医药股份有限公司 一种多替泊芬的应用
AU2022328776B2 (en) * 2021-08-17 2025-09-25 Boston Scientific Scimed, Inc. Devices, systems, and methods for activation of a photoactive agent
CN120957714A (zh) 2023-03-07 2025-11-14 光治疗Asa公司 膀胱癌疗法
WO2026052815A1 (en) 2024-09-05 2026-03-12 Photocure Asa Use of hal in a method for predicting bladder cancer immunotherapy response

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
ATE202076T1 (de) 1995-03-10 2001-06-15 Photocure Asa Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
US20050003154A1 (en) * 2002-12-13 2005-01-06 White Gary L. Laminated building panels having preselected colors
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
GB0724279D0 (en) 2007-12-12 2008-01-23 Photocure Asa Use
CN101891639A (zh) * 2009-05-20 2010-11-24 上海先导化学有限公司 一种制备5-氨基酮戊酸盐酸盐的方法
JP2012529451A (ja) 2009-06-11 2012-11-22 フォトキュア エイエスエイ ５−アミノレブリン酸を含む固体組成物
RU2526803C2 (ru) 2009-06-11 2014-08-27 ФотоКьюэр АСА Полутвердые композиции и фармацевтические продукты
RU2448745C2 (ru) * 2010-05-31 2012-04-27 Олег Феликсович Каган Способ лечения поверхностного рака мочевого пузыря
EP2793679B1 (en) 2011-12-19 2017-05-17 Technical University of Denmark An illumination system for endoscopic applications
CA2880422C (en) * 2012-08-03 2021-02-09 Photocure Asa Derivatives of 5-aminolevulinic acid
GB201221123D0 (en) * 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
BR112018011965A2 (pt) * 2015-12-17 2018-12-04 Photocure Asa método de terapia fotodinâmica (pdt) para câncer de bexiga

Also Published As

Publication number Publication date
DK3389716T3 (da) 2022-04-11
CN108697800A (zh) 2018-10-23
NZ743697A (en) 2024-10-25
JP2019501161A (ja) 2019-01-17
IL259925B (en) 2022-04-01
MX385912B (es) 2025-03-18
US20220152411A1 (en) 2022-05-19
CN119345612A (zh) 2025-01-24
PL3389716T3 (pl) 2022-06-20
JP6995755B2 (ja) 2022-01-17
AU2016372575B2 (en) 2022-12-08
WO2017103285A1 (en) 2017-06-22
AU2016372575A1 (en) 2018-07-12
EP3389716A1 (en) 2018-10-24
EP3389716B1 (en) 2022-03-23
ZA201804530B (en) 2019-09-25
CA3008552C (en) 2024-01-02
ES2910034T3 (es) 2022-05-11
SG11201805000RA (en) 2018-07-30
US11235168B2 (en) 2022-02-01
US11980772B2 (en) 2024-05-14
RU2018123834A3 (https=) 2020-04-13
KR102787192B1 (ko) 2025-03-25
RU2745194C2 (ru) 2021-03-22
CL2018001612A1 (es) 2019-01-11
IL259925A (en) 2018-07-31
RU2018123834A (ru) 2020-01-17
CA3008552A1 (en) 2017-06-22
US20190022404A1 (en) 2019-01-24
KR20180094986A (ko) 2018-08-24

Similar Documents

Publication Publication Date Title
CL2021002669A1 (es) (divisional de solicitud 3443-2018) tratamientos de cancer.
BR112015026247A2 (pt) métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor
MX2017015938A (es) Inhibidores de ezh2 para el tratar linfomas.
MX2023000796A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
BR112018011965A2 (pt) método de terapia fotodinâmica (pdt) para câncer de bexiga
AR092899A1 (es) Uso de masitinib para el tratamiento del cancer en subpoblaciones de pacientes identificados que utilizan factores de prediccion
BR112018012182A2 (pt) dispositivo para tratamento fotodinâmico
MX2016015434A (es) Combinaciones farmaceuticas para tratar cancer.
NI201400095A (es) Metodos para el tratamiento del cáncer de pulmon de celulas no pequeñas utilizando terapia combinada de inhibidor tor cinasa.
MX394252B (es) Tratamiento del cancer usando combinaciones de inhibidores de erk y raf
BR112015026297A2 (pt) terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer
MX2015011296A (es) Dispositivo foto-terapeutico, metodo y uso.
WO2016025635A3 (en) Combination therapy for treating cancer
BR112016007946A2 (pt) combinação farmacêutica, usos da mesma, de plinabulina e de composição, kits ou mistura e método para tratar e/ou prevenir câncer
MX2017000628A (es) Metodos para tratar pacientes de alto riesgo cardiovascular con hipercolesterolemia.
SG10201902664RA (en) Combination therapy for treating cancer
MX2016015437A (es) Combinacion que comprende un glucocorticoide y edo-s101.
WO2016043874A3 (en) Combination therapy for treating cancer
CL2015003343A1 (es) Composición farmacéutica que comprende un agente terapéutico modificado en base a hemoglobina, para el tratamiento para tratar el cáncer, e imágenes de diagnóstico.
BR112015024621A8 (pt) usos de dose unitária de unidades formadoras de colônia de c. novyi, composição farmacêutica compreendendo a referida dose unitária, kit para tratar ou atenuar um efeito de um tumor sólido presente em um ser humano e dose unitária de unidades formadoras de colônia de c. novyi
PE20181332A1 (es) Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos
TW201613578A (en) Pharmaceutical combinations
PH12020550462A1 (en) Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same
AR103118A1 (es) Tratamientos médicos basados en anamorelina
BR112018012009A2 (pt) terapia neoadjuvante para câncer de bexiga

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]